Medico Remedies Limited

Web: medicoremedies.com NSE: MEDICO BSE: 540937 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

21 1(-3%)

Near 52W Low of 20

Volume

2L as on 23, Jun

Open

High

Low

VWAP

52 Week High

52 Week Low

Viand Research Rating

Quality Score

69/100

Growth Score

81/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

173

No. of Shares

8.3

P/E

52.19

P/B

7.65

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

14.66

ROCE

Profit Growth

Listing Date

26-May-22

Rank/Sector Rank

#2725/#172

Promoter Holding

61.38%

FII Holding

0.08%

DII Holding

Price Chart

Price Performance

1 Week2%

1 Month13%

3 Months19%

6 Months2%

1 Year2%

YTD2%

Moving Average

5 Day SMA43

10 Day SMA43

20 Day SMA45

30 Day SMA45

50 Day SMA43

61 Day SMA42

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	44	43	44	44
Resistance 2	44	43	43	44
Resistance 1	43	42	43	43
Pivot Point	43	42	43	43
Support 1	42	42	42	42
Support 2	41	42	42	41
Support 3	41	42	41	40

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,18,698	1745	0%	5%	4%	4%	37	55.5	0.07	11509
2	DIVISLAB	2,43,966	9190	2%	0%	45%	38%	69	55.5	0	2568
3	TORNTPHARM	1,73,208	4554	2%	5%	10%	28%	72	55.5	1.79	2138
4	ZYDUSLIFE	1,11,451	1117	0%	1%	20%	12%	20	55.5	0.31	3560
5	APOLLOHOSP	1,09,276	7600	2%	9%	4%	1%	58	55.5	0.9	2003
6	LAURUSLABS	1,08,738	2012	1%	8%	83%	124%	0	55.5	0.48	890
7	CIPLA	1,06,154	1314	2%	2%	8%	19%	22	55.5	0.02	3862
8	DRREDDY	1,03,873	1244	3%	8%	1%	4%	20	55.5	0.2	4158
9	MANKIND	94,401	2286	4%	1%	8%	7%	49	55.5	0.39	1938
10	AUROPHARMA	90,841	1579	2%	1%	20%	52%	0	55.5	0.19	2415
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 61.38%	(0.01) 61.38%	(0.01) 61.38%	(-1.21) 61.38%	(-1.21) 62.59%	(-3.01) 63.79%	(-6.51) 66.83%	(0.01) 73.34%	(0.01) 73.34%	(0.01) 73.34%	(0.01) 73.34%	(0.01) 73.34%	(0.01) 73.34%	(0.01) 73.34%	(0.01) 73.34%	(0.01) 73.34%	(0.01) 73.34%	(0.01) 73.34%	(0.01) 73.34%	(0.01) 73.34%
FIIs	(0.11) 0.08%	(-0.51) 0.03%	(0.21) 0.49%	(0.21) 0.30%	(0.01) 0.07%	(-0.31) 0.11%	(0.21) 0.39%	(0.01) 0.22%	(-0.11) 0.22%	(-1.01) 0.29%	(0.21) 1.29%	(-0.11) 1.11%	(0.71) 1.19%	(0.51) 0.53%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
DIIs	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.01%	(0.01) 0.01%	(-0.81) 0.01%	(-0.21) 0.78%	(0.01) 0.97%	(0.21) 0.97%	(0.71) 0.74%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
Public	38.55%	38.60%	38.13%	38.30%	37.33%	36.08%	32.00%	25.47%	25.46%	25.63%	25.36%	25.55%	25.46%	26.15%	26.66%	26.65%	26.66%	26.66%	26.66%	26.66%
No. of Shareholders	15,863	16,189	16,562	18,503	16,474	15,424	14,104	12,887	12,902	10,685	6,052	5,264	5,055	3,287	1,777	778	501	119	120	89

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	69.4	56.81	58.68	52.64	38.25	41.3	39.49	39.35	30.8	41.32	29.77	42.36	31.47	27.99	38.85	40.46	33.14	32.28	30.13	29.54
Sales Growth % (YoY)	81%	38%	49%	34%	24%	-	33%	-7%	-2%	48%	-23%	5%	-5%	-13.3%	28.9%	37%	14%	-	-	-
Sales Growth % (QoQ)	22.2%	-3.2%	11.5%	37.6%	-7.4%	4.6%	0.4%	27.8%	-25.5%	38.8%	-29.7%	34.6%	12.4%	-28%	-4%	22.1%	2.7%	7.1%	2%	-
Expenses	66.1	49.66	54.35	49.91	35.43	34.64	36.38	36.94	27.98	36.67	27.04	39.29	29.01	24.82	35.46	37.32	33.32	29.64	28.21	27.37
Operating Profit	3.3	7.15	4.33	2.73	2.82	6.66	3.11	2.41	2.82	4.65	2.73	3.07	2.46	3.17	3.39	3.14	-0.18	2.64	1.92	2.17
OPM %	4.76	12.59	7.38	5.19	7.37	16.13	7.88	6.12	9.16	11.25	9.17	7.25	7.82	11.33	8.73	7.76	-0.54	8.18	6.37	7.35
Other Income	1.17	2.87	0.68	1.72	0.66	0.29	1.43	0.68	0.29	0.58	0.27	0.96	0.31	0.04	0.86	1.55	1.6	0.74	0.23	0.8
Interest	0.41	0.9	0.39	0.24	0.28	0.49	0.28	0.21	0.18	0.25	0.22	0.18	0.17	0.21	0.2	0.17	0.17	0.13	0.2	0.17
Depreciation	0.72	0.8	0.79	0.73	0.77	0.77	0.76	0.75	0.75	0.74	0.72	0.71	0.71	0.73	0.74	0.66	0.59	0.88	0.44	0.47
Profit before tax	3.34	8.32	3.83	3.48	2.43	5.69	3.5	2.13	2.18	4.24	2.06	3.14	1.89	2.27	3.31	3.86	0.66	2.37	1.51	2.33
Tax %	24.55	29.69	25.07	25.86	25.51	23.9	25.14	27.23	27.06	26.89	30.1	22.61	29.63	22.47	32.33	25.65	43.94	20.25	33.11	27.9
Net Profit	2.52	5.86	2.87	2.57	1.82	4.34	2.62	1.55	1.58	3.1	1.45	2.43	1.32	1.77	2.25	2.87	0.36	1.88	1.01	1.68
Net Profit Growth % (QoQ)	-57%	104.2%	11.7%	41.2%	-58.1%	65.6%	69%	-1.9%	-49%	113.8%	-40.3%	84.1%	-25.4%	-21.3%	-21.6%	697.2%	-80.9%	86.1%	-39.9%	-
Net Profit Growth % (YoY)	38.5%	35%	9.5%	65.8%	15.2%	40%	80.7%	-36.2%	19.7%	75.1%	-35.6%	-15.3%	266.7%	-5.9%	122.8%	70.8%	-	-	-	-
TTM Net Profit	13.82	13.12	11.6	11.35	10.33	10.09	8.85	7.68	8.56	8.3	6.97	7.77	8.21	7.25	7.36	6.12	4.93	4.57	2.69	0
EPS in Rs	0.3	0.71	0.35	0.31	0.22	0.52	0.32	0.19	0.19	0.37	0.17	0.29	0.16	0.21	0.27	0.35	0.04	0.23	0.12	0.2

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	206	151	145	140	121	122	89	98	61	54	67	51	45	34
Sales Growth %	36.7%	4.2%	3.2%	16%	-1.1%	38.1%	-9.3%	60.1%	12.2%	-18.4%	30.8%	13.7%	33%	-
Expenses	189	136	132	131	114	117	86	95	58	50	63	48	43	32
Operating Profit	17	15	13	10	7	5	3	3	3	4	4	3	2	1
OPM %	8	10	9	7	6	4.3	3.2	2.8	6	7	5	6	5	4
Other Income	6	3	2	4	2	1	2	2	1	0	0	0	0	0
Interest	2	1	1	1	1	1	1	1	2	1	1	1	1	0
Depreciation	3	3	3	3	2	2	2	2	1	1	1	1	1	0
Profit before tax	18	14	11	10	6	4	2	2	2	2	2	1	1	1
Tax %	27	25	27	28	26	30	26	28	35	4	40	28	34	40
Net Profit	13	10	8	7	5	3	2	2	1	2	1	1	1	0
Net Profit Growth %	30%	25%	14.3%	40%	66.7%	50%	-	100%	-50%	100%	-	-	-	-
EPS in Rs	1.58	1.22	1	0.87	0.58	0.31	0.2	0.19	0.15	0.25	0.35	0.25	0.25	0.21
Dividend Payout %	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Cash from Operating Activity	6	5	2	8	6	-11	1	5	5	-3
Cash from Investing Activity	-5	-3	-3	-7	-2	-17	-3	-4	-5	-3
Cash from Financing Activity	-1	-1	0	-2	-6	18	3	-1	-1	6
Net Cash Flow	1	1	-1	0	-2	-10	0	0	0	0

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	17	17	17	17	17	17	17	4	4	4	4	3	2	2	1	1
Reserves	59	50	46	39	36	27	20	28	26	24	23	13	13	12	7	4
Borrowings	19	13	15	11	8	10	13	15	14	14	13	19	14	8	8	6
Other Liabilities	59	58	43	32	36	34	28	28	32	35	20	13	17	14	14	8
Total Liabilities	153	137	120	99	96	87	77	76	75	76	59	48	46	36	31	18
Fixed Assets	20	21	21	21	21	22	18	15	13	12	7	7	7	8	8	4
CWIP	3	0	0	0	0	0	0	0	2	1	4	3	0	0	0	0
Investments	2	2	2	0	2	1	0	1	0	0	0	0	1	1	0	1
Other Assets	129	114	96	78	73	64	59	59	60	63	48	39	38	27	23	14
Total Assets	153	137	120	99	96	87	77	76	75	76	59	48	46	36	31	18

Delivery

Delivery Data: MEDICO

#	Date	20 139% 49	Value (Cr)	Q/T 330	Del 55	Del 3
1	21-Oct	21	0	157	67	0
2	19-Oct	21	0	210	79	0
3	16-Oct	22	0	204	74	0
4	15-Oct	22	0	185	60	0
5	14-Oct	22	0	187	55	0
6	13-Oct	22	0	168	57	0
7	12-Oct	22	1	211	55	0
8	9-Oct	23	1	236	55	0
9	8-Oct	22	0	138	55	0
10	7-Oct	22	0	188	70	0
11	6-Oct	22	0	124	53	0
12	5-Oct	22	0	159	69	0
13	1-Oct	22	1	221	57	0
14	30-Sep	22	3	244	49	1
15	29-Sep	22	4	234	42	2
16	28-Sep	22	8	249	46	4
17	25-Sep	26	10	417	53	5
18	24-Sep	32	0	101	70	0
19	23-Sep	33	2	137	63	1
20	22-Sep	34	0	121	70	0
21	21-Sep	34	1	145	72	0
22	18-Sep	35	1	196	66	1
23	17-Sep	36	1	93	52	0
24	16-Sep	35	0	148	56	0
25	15-Sep	36	1	75	67	0
26	11-Sep	37	5	51	60	3
27	10-Sep	35	1	214	63	1
28	9-Sep	35	9	217	47	4
29	8-Sep	39	1	123	56	0
30	7-Sep	41	0	95	55	0
31	4-Sep	40	0	70	51	0
32	3-Sep	40	0	58	56	0
33	2-Sep	39	3	156	23	1
34	1-Sep	39	4	109	49	2
35	31-Aug	42	1	285	86	1
36	28-Aug	42	1	167	75	1
37	27-Aug	43	1	141	70	0
38	26-Aug	42	0	115	61	0
39	25-Aug	42	2	303	48	1
40	24-Aug	42	0	86	54	0
41	21-Aug	43	1	111	37	0
42	20-Aug	42	0	89	54	0
43	19-Aug	43	0	56	46	0
44	18-Aug	43	1	118	70	0
45	17-Aug	44	1	114	61	1
46	14-Aug	46	3	168	56	1
47	13-Aug	48	5	610	50	3

Daily Market Cap

Date	Total Market Cap	Change	Chg %
21-Oct	173c	7c	4.06
19-Oct	180c	4c	2.03
17-Oct	184c	0	0
16-Oct	184c	66L	0.36
15-Oct	183c	6c	3.20
14-Oct	189c	2c	1.02
13-Oct	187c	4c	2.31
12-Oct	183c	4c	1.99
09-Oct	179c	6c	3.09
08-Oct	185c	3c	1.69
05-Oct	182c	17L	0.09
01-Oct	182c	3c	1.91
29-Sep	178c	7c	3.59
28-Sep	185c	66c	26.13
25-Sep	251c	21c	7.59
24-Sep	271c	13c	4.47
22-Sep	284c	6c	2.03
17-Sep	290c	2c	0.54
10-Sep	291c	43c	12.82
07-Sep	334c	0	0

Stock Checklist

Price is above from 52 week high low average: 1%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView